Ulrich Laufs

Q: What Schools Are Affiliated With Ulrich Laufs

Ulrich Laufs is affiliated with the following schools: Saarland University, Humboldt University of Berlin, McGill University, University of Cologne, University of Chicago, University of Hamburg, United States Military Academy, Leipzig University, University of Bonn

Ulrich Laufs's AcademicInfluence.com Rankings

Ulrich Laufs

Philosophy

#4114

World Rank

#6508

Historical Rank

Logic

#1647

World Rank

#2450

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Ulrich Laufs Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ulrich Laufs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. (1998) (1937)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel (2017) (1817)
Pleiotropic effects of statins. (2005) (1089)
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase* (1998) (1062)
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. (1998) (1015)
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) (980)
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) (980)
Low-density lipoproteins cause atherosclerotic cardiovascular disease (2018) (936)
Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury (2003) (741)
Pleiotropic Effects of Statins on the Cardiovascular System (2017) (691)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) (630)
Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo (2002) (606)
Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. (2003) (563)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) (541)
Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes (2002) (482)
Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation: Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition (2002) (479)
HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species (2001) (466)
3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 * (1999) (418)
Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase* (1997) (416)
Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice (2000) (402)
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. (2001) (362)
Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis (2004) (359)
Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019) (356)
Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment (2003) (340)
Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall (2009) (326)
Mechanisms of stroke protection by physical activity (2003) (322)
Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension (2012) (305)
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. (2000) (291)
Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription (2000) (290)
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice (2002) (286)
Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis (2005) (283)
Targeting eNOS for stroke protection (2004) (254)
Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure. (2015) (250)
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. (2013) (248)
Physical Activity Improves Long-Term Stroke Outcome via Endothelial Nitric Oxide Synthase–Dependent Augmentation of Neovascularization and Cerebral Blood Flow (2006) (231)
Role of miR-21 in the pathogenesis of atrial fibrosis (2012) (229)
Impact of HMG CoA reductase inhibition on small GTPases in the heart. (2002) (227)
Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. (2008) (225)
Inflammatory Cytokines and Oxidized Low Density Lipoproteins Increase Endothelial Cell Expression of Membrane Type 1-Matrix Metalloproteinase* (1999) (222)
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract (2018) (221)
Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity (2020) (218)
Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects (2005) (217)
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk (2017) (216)
Vascular pathophysiology in response to increased heart rate. (2010) (214)
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance (2019) (211)
Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. (2001) (205)
Clinical review on triglycerides (2019) (194)
Targeting Rho in cardiovascular disease. (2000) (192)
Vascular effects of diet supplementation with plant sterols. (2008) (191)
Beyond lipid-lowering: effects of statins on endothelial nitric oxide (2003) (186)
Role of Rac1 GTPase activation in atrial fibrillation. (2007) (182)
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban (2013) (179)
Effects of Statins on Endothelium and Signaling Mechanisms (2004) (178)
Essential role of interleukin-6 in post-stroke angiogenesis. (2012) (174)
HDL cholesterol: reappraisal of its clinical relevance (2017) (173)
Withdrawal of Statin Treatment Abrogates Stroke Protection in Mice (2003) (169)
Direct vascular effects of HMG-CoA reductase inhibitors. (2000) (166)
Erratum (1997) (162)
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy (2019) (161)
The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients With Coronary Artery Disease and Normal Glucose Tolerance (2007) (160)
Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice (2008) (156)
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. (2020) (153)
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction (2002) (151)
Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment (2000) (148)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). (2018) (147)
Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. (2010) (147)
The PPAR-γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells (2007) (146)
Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. (2013) (144)
Familial hypercholesterolaemia: A global call to arms. (2015) (144)
Raloxifene Improves Endothelial Dysfunction in Hypertension by Reduced Oxidative Stress and Enhanced Nitric Oxide Production (2002) (135)
Chronic Heart Failure and Ischemic Stroke (2011) (126)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation (2019) (125)
Controversial role of plant sterol esters in the management of hypercholesterolaemia (2008) (125)
Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy (2007) (123)
Pleiotropic effects of HMG-CoA reductase inhibitors (2002) (122)
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. (2015) (119)
Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction. (2014) (117)
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. (2019) (115)
Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study (2018) (114)
Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase* (2008) (113)
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association (2018) (112)
Renal denervation in moderate treatment-resistant hypertension. (2013) (111)
Strategies to improve drug adherence. (2011) (109)
Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension (2015) (106)
Circular RNA Splicing. (2018) (105)
Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment. (2014) (100)
Isoprenoid metabolism and the pleiotropic effects of statins (2003) (99)
Plant Sterols the Better Cholesterol in Alzheimer's Disease? A Mechanistical Study (2013) (99)
Heart rate reduction in cardiovascular disease and therapy (2010) (99)
Angiotensin II Impairs Endothelial Progenitor Cell Number and Function In Vitro and In Vivo: Implications for Vascular Regeneration (2011) (98)
The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation* (2013) (98)
Discontinuation of Statin Treatment in Stroke Patients (2006) (97)
Intravenous Rosuvastatin for Acute Stroke Treatment: An Animal Study (2008) (97)
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. (2012) (96)
Antioxidative effects of statins (2008) (92)
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia (2020) (90)
Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation. (2011) (89)
Dietary intake of plant sterols stably increases plant sterol levels in the murine brain (2012) (88)
Primary prevention of stroke: blood pressure, lipids, and heart failure. (2011) (87)
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9) (2015) (87)
Application and Interpretation of High-Sensitivity Cardiac Troponin Assays in Patients With Acute Ischemic Stroke (2015) (87)
Cardiovascular disease and dyslipidemia: beyond LDL. (2011) (86)
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. (2016) (85)
Effects of DPP-4 inhibition on cardiac metabolism and function in mice. (2011) (84)
A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling. (2015) (84)
Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. (2006) (84)
Modulation of Bradykinin Receptor Ligand Binding Affinity and Its Coupled G-proteins by Nitric Oxide* (1997) (84)
Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (2008) (83)
Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. (1997) (82)
Stress Worsens Endothelial Function and Ischemic Stroke via Glucocorticoids (2011) (78)
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
Down-regulation of Rac-1 GTPase by Estrogen (2003) (76)
Prognostic relevance of cardiac troponin T levels and their dynamic changes measured with a high-sensitivity assay in acute ischaemic stroke: analyses from the TRELAS cohort. (2014) (75)
Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk (2015) (74)
The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. (2007) (74)
Insular Cortex Lesions, Cardiac Troponin, and Detection of Previously Unknown Atrial Fibrillation in Acute Ischemic Stroke: Insights From the Troponin Elevation in Acute Ischemic Stroke Study (2015) (74)
Effects of surgical face masks on cardiopulmonary parameters during steady state exercise (2020) (73)
Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study. (2016) (73)
Treatment Options for Statin-Associated Muscle Symptoms. (2015) (72)
Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis (2015) (72)
Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients. (2016) (71)
Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. (1999) (71)
Heart Rate Contributes to the Vascular Effects of Chronic Mental Stress: Effects on Endothelial Function and Ischemic Brain Injury in Mice (2011) (69)
Age-related medication adherence in patients with chronic heart failure: A systematic literature review. (2015) (69)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021) (68)
Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis. (2012) (66)
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease (2017) (65)
Withdrawal of statins in patients with acute coronary syndromes. (2003) (64)
Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future (2020) (64)
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease (2017) (62)
Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. (2010) (61)
Alcohol and red wine: impact on cardiovascular risk. (2004) (61)
Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum. (2013) (59)
Echocardiographic characteristics of patients with SARS-CoV-2 infection (2020) (59)
Heart failure with preserved ejection fraction: current management and future strategies (2017) (58)
Aneurysms of the ascending aorta. (2012) (57)
Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis. (2011) (57)
ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. (2009) (57)
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. (2013) (56)
Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk. (2010) (55)
Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis. (2013) (55)
Drug adherence in patients taking oral anticoagulation therapy (2014) (54)
Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins (2017) (53)
Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells. (2008) (52)
Expert opinion paper on atrial fibrillation detection after ischemic stroke (2018) (52)
Familial hypercholesterolemia: developments in diagnosis and treatment. (2014) (52)
Arrhythmia causes lipid accumulation and reduced glucose uptake (2015) (52)
Improving exercise capacity and quality of life using non‐invasive heart failure treatments: evidence from clinical trials (2020) (52)
Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial. (2021) (52)
The Relationships of Markers of Cholesterol Homeostasis with Carotid Intima-Media Thickness (2010) (51)
Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial (2019) (50)
Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl. (2004) (49)
Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress (2018) (49)
Blocking Interferon β Stimulates Vascular Smooth Muscle Cell Proliferation and Arteriogenesis* (2010) (48)
Down‐regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen‐2) 27 rats (1997) (46)
Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. (2010) (46)
Ferulic acid, a bioactive component of rice bran, improves oxidative stress and mitochondrial biogenesis and dynamics in mice and in human mononuclear cells. (2017) (46)
Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis (2009) (46)
Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. (2011) (46)
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk (2016) (46)
Validation of an isotope dilution gas chromatography-mass spectrometry method for analysis of 7-oxygenated campesterol and sitosterol in human serum. (2011) (45)
Combination lipid-lowering therapy as first-line strategy in very high-risk patients. (2021) (44)
Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance (2015) (43)
Mitral valve interventions in heart failure (2018) (41)
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. (2020) (41)
Troponin elevation in acute ischemic stroke (TRELAS) - protocol of a prospective observational trial (2011) (40)
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia. (2016) (38)
PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR (2016) (38)
The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice (2010) (37)
Effects of endurance training on serum lipids. (2017) (37)
Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention. (2014) (37)
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. (2011) (37)
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art Review. (2020) (36)
Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS): Rationale and design of a prospective randomized multicenter study. (2016) (35)
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges (2021) (34)
Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis. (2007) (34)
Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis. (2012) (33)
Prospective study of telomere length and LINE-1 methylation in peripheral blood cells: the role of B vitamins supplementation (2016) (33)
The Diagnosis and Treatment of Hypertriglyceridemia. (2019) (33)
Diesel Exhaust Particles Impair Endothelial Progenitor Cells, Compromise Endothelial Integrity, Reduce Neoangiogenesis, and Increase Atherogenesis in Mice (2013) (33)
Improvement of Endothelial Function of the Corpus Cavernosum in Apolipoprotein E Knockout Mice Treated with Irbesartan (2008) (33)
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) (2013) (33)
Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE−/− mice (2011) (33)
Exercise Promotes Collateral Artery Growth Mediated by Monocytic Nitric Oxide (2015) (32)
Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. (2013) (32)
Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac TroponinCLINICAL PERSPECTIVE (2016) (32)
Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010 (2010) (31)
Heart rate on admission independently predicts in-hospital mortality in acute ischemic stroke patients. (2014) (31)
Heart failure and statins—Why do we need a clinical trial? (2005) (31)
Effects of Renal Sympathetic Denervation on Exercise Blood Pressure, Heart Rate, and Capacity in Patients With Resistant Hypertension (2014) (30)
Pulsatile venoarterial perfusion using a novel synchronized cardiac assist device augments coronary artery blood flow during ventricular fibrillation. (2015) (29)
Vascular effects of oxysterols and oxyphytosterols in apoE -/- mice. (2015) (29)
[Strategies to improve medication adherence]. (2011) (28)
Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population (2016) (28)
Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects. (2006) (28)
PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects (2020) (28)
Practical aspects in the management of statin-associated muscle symptoms (SAMS). (2017) (27)
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice. (2015) (27)
Rapid effects of statins: from prophylaxis to therapy for ischemic stroke. (2003) (27)
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling. (2019) (27)
Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study (2021) (26)
Perceived psychosocial stress and cardiovascular risk factors in obese and non-obese patients (2007) (26)
Marathon running increases circulating endothelial- and thrombocyte-derived microparticles (2018) (26)
AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes (2017) (26)
New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function. (2019) (25)
Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease (2014) (25)
Heart Rate Reduction by Ivabradine Improves Aortic Compliance in Apolipoprotein E-Deficient Mice (2012) (25)
Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophy. (2010) (25)
Systems Genetics of Liver Fibrosis: Identification of Fibrogenic and Expression Quantitative Trait Loci in the BXD Murine Reference Population (2014) (24)
Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation. (2012) (24)
Increased plant sterol deposition in vascular tissue characterizes patients with severe aortic stenosis and concomitant coronary artery disease (2015) (24)
Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension (2015) (24)
HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk. (2006) (24)
Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia (2001) (23)
Analyses of drugs stored at home by elderly patients with chronic heart failure (2015) (23)
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation (2017) (23)
Rate of Cough During Treatment With Angiotensin‐Converting Enzyme Inhibitors: A Meta‐Analysis of Randomized Placebo‐Controlled Trials (2019) (23)
In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review (2017) (23)
Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice (2019) (23)
New metrics needed to visualize the long-term impact of early LDL-C lowering on the cardiovascular disease trajectory. (2015) (23)
Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study (2010) (22)
Non‐adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT (2016) (22)
The year in cardiology 2018: prevention (2019) (22)
Positionspapier zur Detektion von Vorhofflimmern nach ischämischem Schlaganfall (2017) (21)
The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis (2014) (21)
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk (2014) (21)
Induction of Endothelial-Leukocyte Interaction by Interferon-γ Requires Coactivation of Nuclear Factor-κB (2001) (21)
Impact of COVID-19 lockdown on endurance capacity of elite handball players. (2020) (21)
An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. (2010) (21)
Beyond statins: what to expect from add-on lipid regulating therapy? (2013) (21)
C-kit(+) resident cardiac stem cells improve left ventricular fibrosis in pressure overload. (2015) (20)
LDL-Cholesterol: Standards of Treatment 2016: A German Perspective (2016) (20)
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. (2018) (20)
Ramipril and Telmisartan Exhibit Differential Effects in Cardiac Pressure Overload-Induced Hypertrophy Without an Additional Benefit of the Combination of Both Drugs (2013) (20)
The relationships of phytosterols and oxyphytosterols in plasma and aortic valve cusps in patients with severe aortic stenosis. (2014) (20)
PHARMacy‐based interdisciplinary program for patients with Chronic Heart Failure (PHARM‐CHF): rationale and design of a randomized controlled trial, and results of the pilot study (2018) (20)
Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels (2017) (20)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014)) (2019) (19)
Telemonitoring in patients with chronic heart failure and moderate depressed symptoms: results of the Telemedical Interventional Monitoring in Heart Failure (TIM‐HF) study (2020) (19)
Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease. (2014) (19)
Oxidation of sitosterol and transport of its 7-oxygenated products from different tissues in humans and ApoE knockout mice (2017) (19)
Renal sympathetic denervation increases urinary sodium excretion in patients with treatment resistant hypertension (2013) (19)
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C (2020) (19)
Cardiovascular risk algorithms in primary care: Results from the DETECT study (2019) (19)
Methamphetamine‐related cardiovascular diseases (2020) (19)
Association of vitamin D status and blood pressure response after renal denervation (2013) (18)
Evaluating patients’ comprehensibility of a standardized medication plan (2016) (18)
Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling (2017) (18)
Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk (2018) (18)
Clinical Trial Updates and Hotline Sessions presented at the Scientific Session 2007 of the American heart association (2008) (17)
Obesity–An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances (2021) (17)
Loss of Mitochondrial Ca2+ Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy. (2021) (17)
Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events. (2018) (16)
The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption (2018) (16)
Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study. (2019) (16)
Neurologische Aspekte bei chronischer Herzinsuffizienz (2011) (16)
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials (2022) (15)
Early Hemodynamic Improvement after Percutaneous Mitral Valve Repair Evaluated by Noninvasive Pressure-Volume Analysis. (2016) (15)
Cardiological evaluation after cerebral ischaemia (2010) (15)
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort. (2019) (15)
Food supplementation with rice bran enzymatic extract prevents vascular apoptosis and atherogenesis in ApoE−/− mice (2017) (15)
Irregular pacing of ventricular cardiomyocytes induces pro‐fibrotic signalling involving paracrine effects of transforming growth factor beta and connective tissue growth factor (2019) (15)
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany (2020) (15)
[Cholesterol homeostasis and cardiovascular risk]. (2011) (15)
Enrichment of G protein α-subunit mRNAs in the AV-conducting system of the mammalian heart (1995) (14)
Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure (2019) (14)
The year in cardiology: cardiovascular prevention. (2020) (14)
Acute effects of statins. (2012) (14)
Alternative Treatment Regimens With the PCSK9 Inhibitors Alirocumab and Evolocumab: A Pharmacokinetic and Pharmacodynamic Modeling Approach (2017) (14)
New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease (2019) (13)
Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease (2019) (13)
Angiotensin-receptor blockade, cancer, and concerns. (2010) (13)
Cardiac effects of statins--advancements and open questions. (2005) (13)
Endogenous nitric oxide formation in cardiac myocytes does not control respiration during β‐adrenergic stimulation (2017) (13)
Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease (2021) (13)
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players (2021) (12)
Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice (2019) (12)
Medication knowledge of patients hospitalized for heart failure at admission and after discharge (2016) (12)
Red Wine Prevents the Acute Negative Vascular Effects of Smoking. (2017) (12)
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project. (2020) (12)
[Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society]. (2010) (12)
[Plant sterols as dietary supplements for the prevention of cardiovascular diseases]. (2008) (12)
Risk prediction with triglycerides in patients with stable coronary disease on statin treatment (2014) (12)
Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study (2019) (12)
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave (2021) (12)
[Regulation of endothelial NO production by Rho GTPase]. (1999) (12)
Pathological phenotypes of LDL particles. (2018) (12)
Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats (2016) (11)
Moving beyond the "LDL hypothesis". (2015) (11)
Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. (2001) (11)
Reduced telomere shortening in lifelong trained male football players compared to age-matched inactive controls. (2020) (11)
7β-Hydroxysitosterol crosses the blood–brain barrier more favored than its substrate sitosterol in ApoE−/− mice (2015) (11)
Activation of Guanine Nucleotide-binding Proteins and Induction of Endothelial Tissue-type Plasminogen Activator Gene Transcription by Alcohol* (1999) (11)
Statin intolerance (2015) (10)
First-in-man analysis of the i-cor assist device in patients with cardiogenic shock (2015) (10)
Acute cardiopulmonary responses to strength training, high-intensity interval training and moderate-intensity continuous training (2019) (10)
The Berlin ‘Cream&Sugar’ Study: the Prognostic Impact of an Oral Triglyceride Tolerance Test in Patients after Acute Ischaemic Stroke (2010) (10)
CaRe high - Cascade screening and registry for high cholesterol in Germany. (2017) (10)
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). (2022) (10)
Who does not need a statin: too late in end-stage renal disease or heart failure? (2008) (10)
The Medical Case for the Development of an Intravenous Statin Formulation – Beyond Ischemic Stroke (2008) (10)
Regulation der endothelialen NO-Produktion durch Rho-GTPasen (1999) (10)
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players (2021) (10)
Kardiologische Diagnostik nach zerebraler Ischämie (2010) (10)
[Consensus paper on peri-interventional and postinterventional stroke during cardiac catheter procedures]. (2009) (9)
Curriculum Herzinsuffizienz (2018) (9)
Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association (2008) (9)
Gene Therapy Targeting PCSK9 (2022) (9)
[Neurological aspects of chronic heart failure]. (2011) (9)
Vascular beta-adrenergic receptor adenylyl cyclase system from renin-transgenic hypertensive rats. (1998) (9)
Long‐Term Hemodynamic Improvement after Transcatheter Mitral Valve Repair (2018) (9)
The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta‐analysis (2021) (9)
The dual PPAR-alpha/gamma agonist aleglitazar increases number and function of endothelial progenitor cells: implications for vascular function and atherogenesis (2013) (9)
Cholesterol-lowering foods and reduction in serum cholesterol levels. (2011) (9)
Down-regulation of Rac1 GTPase by Estrogen (2003) (9)
Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants (2020) (8)
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey (2020) (8)
Lipid management with statins. The lower the better? (2004) (8)
Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH (2012) (8)
Margarines supplemented with low dose n-3 fatty acids are not effective in secondary prevention. (2012) (8)
Heart failure is independently associated with white matter lesions: insights from the population‐based LIFE‐Adult Study (2020) (8)
Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs (2022) (8)
Regional Disparities of Left Atrial Appendage Wall Contraction in Patients With Sinus Rhythm and Atrial Fibrillation. (2019) (8)
HMG-CoA-Reduktasehemmer und Schlaganfallrisiko (1998) (8)
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study (2021) (8)
Leucocyte immunoglobulin-like receptor subfamily-B5 (LILRB5) genetic variation and statin-associated muscle symptoms: another piece in a puzzling puzzle (2017) (8)
Renal Denervation in the Treatment of Hypertension (2013) (8)
The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM‐CHF randomized controlled trial (2020) (8)
Chronic Eosinophilic Pneumonia with Atypical Radiographic Presentation (1998) (8)
Inhibitory effect of estrogen on Rac1-expression in monocytes. (2009) (8)
Simplified algorithm to facilitate communication of familial hypercholesterolaemia. (2015) (7)
[LDL-Cholesterol--Is there an "LDL hypothesis"?]. (2015) (7)
Guanidinylated Apolipoprotein C3 (ApoC3) Associates with Kidney and Vascular Injury (2021) (7)
Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis. (2020) (7)
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study (2020) (7)
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. (2022) (7)
Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (7)
Enrichment of G protein alpha-subunit mRNAS in the AV-conducting system of the mammalian heart. (1995) (7)
Vaccination to prevent atherosclerotic cardiovascular diseases. (2017) (7)
Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM‐HF2 trial (2020) (7)
Einsatzgebiete und praktischer Nutzen der kardialen Marker BNP und NT-proBNP (2017) (7)
NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials (2021) (7)
HMG-CoA Reductase Inhibitors in Chronic Heart Failure (2012) (7)
Statin intolerance: myths and facts. (2020) (7)
Analysis of Regional Right Ventricular Function by Tissue Doppler Imaging in Patients with Aortic Stenosis (2019) (7)
Physical exercise and endothelial progenitor cells. (2007) (7)
Genetic Variation in Sodium‐glucose Cotransporter 2 and Heart Failure (2021) (7)
Inhibition of Rac1 GTPase Decreases Vascular Oxidative Stress, Improves Endothelial Function, and Attenuates Atherosclerosis Development in Mice (2021) (7)
Extracellular NLRP3 inflammasome particles are internalized by human coronary artery smooth muscle cells and induce pro-atherogenic effects (2021) (7)
Positionspapier zur Statintherapie (2007) (7)
Duale Plättchenaggregationshemmung bei Koronarstents: Zwei Stellungnahmen im Diskussionsforum der Arzneimittelkommission der deutschen Ärzteschaft (Arzneiverordnung in der Praxis, September 2008) - Online ZFA (2011) (7)
Analysis of chronic aortic regurgitation by 2D and 3D echocardiography and cardiac MRI (2018) (7)
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine. (2018) (6)
Expert opinion paper on cardiac imaging after ischemic stroke (2021) (6)
Progression of left ventricular thrombus in Loeffler’s endocarditis without eosinophilia—case report and review of the literature (2019) (6)
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: Analysis of pooled patient-level data from phase 3 clinical trials (2020) (6)
[Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP]. (2017) (6)
Heart failure, cognition, and brain damage. (2021) (6)
[The "French Paradox"--effects of alcohol, wine and wine polyphenols on the heart]. (2002) (6)
Unraveling the steroid hormone response in male marathon runners: Correlation of running time with aldosterone and progesterone (2019) (6)
Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants (2021) (6)
Long-Term Follow-up of Enhanced Holter-Electrocardiography Monitoring in Acute Ischemic Stroke (2021) (6)
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (6)
Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome (2022) (6)
Nitric oxide-donating statins: a new concept to boost the lipid-independent effects. (2012) (6)
Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome. (2018) (6)
Antioxidative eVects of statins (2008) (5)
Speckle tracking echocardiography in a patient with viral myocarditis and acute myocardial infarction. (2020) (5)
Sunday, 26 August 2012 (2012) (5)
Who does not need a statin: too late in end-stage renal disease or heart failure? (2009) (5)
A SARS-Cov2-negative corona victim (2020) (5)
Platelet Activation , and Protects From Cerebral Ischemia in Normocholesterolemic Mice Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes , Decreases (2000) (5)
Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study (2020) (5)
Hospitalizations for heart failure: still major differences between East and West Germany 30 years after reunification (2021) (5)
[Clinical importance of HDL cholesterol]. (2017) (5)
Konsensuspapier „Peri- und postinterventioneller Schlaganfall bei Herzkatheterprozeduren“ (2009) (5)
Abstract 18220: High-intensity Interval Training Reduces P53 Expression and Increases Telomerase Activity in Circulating Mononuclear Cells of Untrained Subjects (2012) (5)
Echocardiographic analysis of acute effects of percutaneous mitral annuloplasty on severity of secondary mitral regurgitation (2020) (4)
[The cardiovascular risk factor in obesity]. (2000) (4)
Herzfrequenz: klinische Variable und Risikomarker (2014) (4)
"Dear Doctor" Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription. (2020) (4)
Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia. (2018) (4)
Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis (2021) (4)
[Heart rate and rate control : Prognostic value in cardiovascular diseases]. (2012) (4)
Angiography-based quantitative coronary contrast-flow ratio measurements correlate with myocardial ischemia assessed by stress MRI (2020) (4)
[Medication adherence in patients with chronic diseases: significance and new approaches]. (2011) (4)
Possible new options and benefits to detect myocarditis, right ventricular remodeling and coronary anomalies by echocardiography in systematic preparticipation screening of athletes (2020) (4)
STICKSTOFFMONOXID ALS SIGNALMOLEKUL IM HERZ-KREISLAUFSYSTEM: NOBELPREIS FUR MEDIZIN 1998 (2009) (4)
[ESC Guidelines 2016 - Heart Failure]. (2017) (4)
Bad gut feeling: ACE inhibitor induced intestinal angioedema (2009) (4)
Attenuation of the Heartbeat-Evoked Potential in Patients With Atrial Fibrillation. (2022) (4)
Mitochondrial regulation of reactive oxygen species (ROS) production—Unexpected observations in early postnatal cerebral vasculature (2016) (4)
Cardiac sarcoidosis: a challenging diagnosis (2018) (4)
“Pure” severe aortic stenosis without concomitant valvular heart diseases: echocardiographic and pathophysiological features (2020) (4)
Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H2-histamine-receptor activation in isolated atria of transgenic mice (2021) (4)
Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy (2020) (4)
[Chronic coronary syndrome : New classification of stable coronary artery disease]. (2020) (4)
[HMG-CoA reductase inhibitor and risk of stroke]. (1998) (4)
Klinische Bedeutung des HDL-Cholesterins (2017) (4)
[Stable coronary artery disease -- case report]. (2006) (4)
Efficacy and Safety of Bempedoic Acid + Ezetimibe Fixed-Dose Combination in Patients at High CVD Risk and with Elevated LDL-C Receiving Maximally Tolerated Statin Therapy (2019) (3)
Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment (2000) (3)
[Atorvastatin therapy under clinical practice conditions - which LDL-C levels are achieved in patients at very high cardiovascular risk?] (2017) (3)
HMG-CoA reductase inhibitors reduce cerebral infarct size by upregulating endothelial nitric oxide synthase (1998) (3)
Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (2022) (3)
No effects of PCSK9-inhibitor treatment on spatial learning, locomotor activity, and novel object recognition in mice (2020) (3)
Lipoprotein(a): Behandlung eines unterschätzten kardiovaskulären Risikomarkers (2020) (3)
Abstract 2393: Physical Activity Improves Long-Term Stroke Outcome via eNOS-Dependent Augmentation of Neo-Vascularization and Cerebral Blood Flow (2006) (3)
ESC-Leitlinie 2016 – Herzinsuffizienz (2017) (3)
Nuclear run-on assay to study gene transcription in vascular cells. (1999) (3)
TCT-14 Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension (2012) (3)
[European dyslipidemia guidelines 2019 : What is new?] (2019) (3)
Kommentar zu den Leitlinien (2019) der ESC/EAS zur Diagnostik und Therapie der Dyslipidämien (2020) (3)
Extracellular Inflammasome Particles Are Released After Marathon Running and Induce Proinflammatory Effects in Endothelial Cells (2022) (3)
Statins Do More Than Lower Cholesterol-Depending on What You Eat? (2021) (3)
ER-Stress and Senescence Coordinately Promote Endothelial Barrier Dysfunction in Diabetes-Induced Atherosclerosis (2022) (3)
Development and implementation of blood pressure screening and referral guidelines for German community pharmacists (2020) (3)
SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy (2021) (3)
[Poor medication adherence and worsening of heart failure--a vicious circle]. (2014) (3)
Monday, 27 August 2012 (2012) (3)
Letter by Weingartner et al regarding article, "Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans". (2012) (3)
Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy (2022) (3)
The year in cardiology 2017: prevention (2018) (3)
Atrial fibrillation in heart failure: Current treatment of patients with remodeled atria (2008) (3)
Hypertriglyceridämie:prognostische Bedeutung und Therapiemöglichkeiten (2011) (3)
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia (2022) (3)
Cutaneous manifestations in familial hypercholesterolaemia. (2021) (2)
THERAPIE DER HERZINSUFFIZIENZ MIT BETA-REZEPTORENBLOCKERN (1999) (2)
Neue AHA- und ACC-Leitlinie zur Risikoreduktion von Herz-Kreislauf-Erkrankungen durch Cholesterinsenkung (2014) (2)
Bempedoinsäure – Wirkmechanismus und klinische Studien (2020) (2)
Europäische Leitlinien zu Lipiden 2019 (2019) (2)
Medikamentenadhärenz bei chronischen Erkrankungen (2011) (2)
LDL-Cholesterin: Von der Hypothese zur Kausalität (2015) (2)
Atorvastatin-Therapie in der Praxis – LDL-Werte bei Patienten mit sehr hohem kardiovaskulären Risiko (2017) (2)
Herzfrequenz und Frequenzkontrolle (2011) (2)
BNP und NT-proBNP: Zwei kardiale Marker werden „erwachsen“ (2016) (2)
67-jährige Patientin mit abdominellen Schmerzen und ausgeprägter Peritonitis (2009) (2)
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021 (2022) (2)
Analysis of left ventricular rotational deformation by 2D speckle tracking echocardiography: a feasibility study in athletes (2021) (2)
[Primary and secondary prevention of the acute coronary syndrome]. (2006) (2)
Activity of Rac 1-GTPase and Represents a Target for Statin Treatment Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased (2003) (2)
[Nitric oxide as a signal molecule in the cardiovascular system. Nobel Prize for Medicine in 1998]. (1998) (2)
Cardiopulmonary bypass reduces myocardial oxidative stress, inflammation and increases c-kit+CD45− cell population in newborns (2017) (2)
Significance of cholesterol-independent effects of statins (2002) (2)
[Treatment of lipid disorders]. (2014) (2)
Response to Letter to the editors of Hopkins et al.: Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity: the numbers do not add up (2020) (2)
[New findings on the action of HMG-CoA-reductase inhibitors]. (2008) (2)
Studienkonzept MonDAFIS: Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (2015) (2)
[PCSK9 inhibitors : Recommendations for patient selection]. (2016) (2)
Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls. (2020) (2)
[Heart rate: clinical variable and risk marker]. (2014) (2)
Effects of Medical Face Masks on Physical Performance in Patients With Coronary Artery Disease or Hypertension. (2022) (2)
Do patients with diabetes type 2 or chronic heart failure understand a medication plan? (2017) (2)
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials (2022) (2)
Effects of cardio-selective beta-blockade on plasma catecholamines and performance during different forms of exercise. (2019) (2)
Leptin treatment has vasculo-protective effects in lipodystrophic mice (2022) (2)
Revisited Upper Reference Limits for Highly Sensitive Cardiac Troponin T in Relation to Age, Sex, and Renal Function (2021) (2)
Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials (2020) (2)
Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany (2022) (2)
Statins and Ezetimibe (2015) (2)
Alirocumab efficacy and safety by body mass index: a pooled analysis from 10 Phase 3 ODYSSEY trials. (2020) (2)
Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial (2021) (2)
[Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?]. (2009) (2)
Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients (2022) (2)
[State of the Art: Statin Therapy]. (2021) (2)
Comparison of unilateral versus bilateral renal denervation in patients with resistant hypertension (2013) (2)
[Hypertricglyceridemia: prognostic impact and treatment options]. (2011) (2)
Chronisches Koronarsyndrom (2020) (2)
FACTORS THAT INFLUENCE BEMPEDOIC ACID-MEDIATED REDUCTIONS IN HIGH-SENSITIVITY C-REACTIVE PROTEIN: ANALYSIS OF POOLED PATIENT-LEVEL DATA FROM PHASE 3 CLINICAL TRIALS (2020) (2)
[HDL and CETP in atherogenesis]. (2010) (2)
Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk (2022) (2)
[Management of different cardiovascular risk factors with a combination tablet (polypill)]. (2018) (2)
Detection of new-onset atrial fibrillation in heart failure patients using daily non-invasive ECG monitoring in the TIM-HF2 telemedicine trial (2020) (2)
Procedural parameters during renal denervation and change of blood pressure in patients with resistant hypertension (2013) (1)
Left ventricular mechanical dispersion in flow-gradient patterns of severe aortic stenosis with narrow QRS complex (2020) (1)
[Mechanisms and potential of the therapeutic stimulation of arteriogenesis]. (2009) (1)
Abstract 965: Prevention of Apoptosis in Endothelial Progenitor Cells Treated with the PPAR-{gamma} Agonist Pioglitazone (2006) (1)
Response to the letter to the editor by Kampert et al. entitled “Impact of wearing a facial covering on aerobic exercise capacity in the COVID-19 Era: is it more than a feeling?” (2020) (1)
Abstract 13175: Fasting and Postprandial Triglycerides and Cardiovascular Event in Stable Coronary Artery Disease: 4-Years Follow-Up of the Homburg Cream & Sugar Study (2014) (1)
Abstract 10940: Leptin Treatment Protects the Endothelium from Inflammation, Increased Permeability and Endothelial-to-Mesenchymal Transition (2021) (1)
Abstract 16261: PPAR-Gamma Agonist-Induced Telomerase Activation in Endothelial Cells and Endothelial Progenitor Cells is Mediated by the Survival Kinase Akt (2011) (1)
General health of patients with diabetic macular edema—The LIPSIA study (2021) (1)
BEMPEDOIC ACID EFFICACY AND SAFETY IN HIGH CVD RISK PATIENTS TREATED WITH OR WITHOUT EZETIMIBE: POOLED ANALYSIS OF 4 PHASE 3 CLINICAL TRIALS (2020) (1)
[Cardiac arrhythmias in patients with chronic autoimmune diseases]. (2019) (1)
Abstract 1380: Beneficial Effects of Long-term Endurance Exercise on Leukocyte Telomere Biology (2009) (1)
217 Free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and can be inhibited by statin treatment (2003) (1)
Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia (2022) (1)
Letter on ‘Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial’: reply (2020) (1)
Fettstoffwechsel, Übergewicht und Ernährung, Diabetes (2000) (1)
[Epidemiology, etiology and pathophysiology of heart failure]. (2016) (1)
Myocardial work - a modern tool to detect possible compensation mechanism of deformation in infective myocarditis with preserved left ventricular function (2020) (1)
Antioxidative Properties of Statins in the Heart (2010) (1)
Abstract 1069: Cardiac Overload Is Associated With Cardiac Angiogenesis By Bone Marrow-derived Cells And Upregulation Of Myocyte Precursor Cells (2007) (1)
Primärprävention der koronaren Herzkrankheit (2019) (1)
A Mendelian Randomization Analysis Of Lipoprotein(A) Lowering And Cardiovascular Risk Stratified By Ldl Cholesterol, Gender, And Antiplatelet Therapy: Implications For Clinical Outcome Trials (2019) (1)
Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 2) (2022) (1)
The year in cardiology 2016: prevention (2017) (1)
PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE (2020) (1)
Statine als neue Therapiemöglichkeit der Osteoporose (2001) (1)
Travelling with heart failure: risk assessment and practical recommendations (2022) (1)
Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation (2021) (1)
Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study (2020) (1)
Global longitudinal strain differentiates physiological hypertrophy from maladaptive remodeling (2022) (1)
P3996Prospective study of differential effects of aerobic endurance, interval and resistance training on telomerase activity and telomere length in circulating mononuclear cells (2017) (1)
Lipoproteinapherese (2022) (1)
Response to: Jiménez-Pavon et al. and Patanè. (2019) (1)
Konsensuspapier "Peri- und postinterventioneller Schlaganfall bei Herzkatheterprozeduren" (2009) (1)
[Primary prevention of coronary heart disease : Evidence-based drug treatment]. (2019) (1)
Healthy and Unhealthy Cardiac Progenitor Cells Modify the Pathogenesis of Myocardial Diseases. (2016) (1)
Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. (2023) (1)
Abstract 3787: Effects of Running Exercise on Aortic Telomere Regulating Proteins, Survival Pathways and Apoptosis (2008) (1)
P912 Echocardiographic analysis of acute effects after treatment of functional mitral regurgitation by percutaneous mitral annuloplasty (2020) (1)
Alirocumab efficacy and safety by body mass index: Pooled analysis from 10 Phase 3 ODYSSEY trials (2018) (1)
Tuesday, 28 August 2012 (2012) (1)
Abstract 3816: Endothelial Nitric Oxide Synthase of the Bone Marrow Regulates Cardiac Angiogenesis in Pressure Overload (2009) (1)
Therapie von Fettstoffwechselstörungen (2013) (1)
Konservative Therapie der stabilen koronaren Herzkrankheit (2012) (1)
Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome (2021) (1)
185-OR: Efficacy and Safety of Bempedoic Acid in Patients with Diabetes, Prediabetes, and Normoglycemia: Analysis of Pooled Patient-Level Data from Four Phase 3 Clinical Trials (2020) (1)
Mechanismen und Möglichkeiteneiner therapeutischen Stimulation der Arteriogenese (2009) (1)
Abstract 1929: Endogenous Cholesterol Synthesis Is Associated With Increased Carotid Intima-Media-Thickness (2008) (1)
[67-year-old patient with abdominal pain and pronounced peritonitis]. (2009) (1)
Cardiopulmonary bypass reduces myocardial oxidative stress, inflammation and increases c-kit+CD45− cell population in newborns (2017) (1)
Update Therapie der Herzinsuffizienz 2019 (2020) (1)
What is 'remnant cholesterol'? (2023) (1)
The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project. (2023) (1)
Acute cardiopulmonary responses to strength training, high-intensity interval training and moderate-intensity continuous training (2019) (1)
[Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?]. (2010) (1)
State of the Art: Therapie mit Statinen (2021) (1)
Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“) (2018) (1)
Macrohage depletion using clodronate liposomes delays exercise-induced collateral artery growth.3 (2013) (1)
Reductions of left-ventricular mass and improvements in left-ventricular diastolic function following renal denervation do not correlate with blood pressure or heart rate reduction (2013) (1)
Inhibition of aldosteronsynthase regulates miR-21 during atrial fibrillation in mice (2013) (0)
Physical activity promotes angio- and vasculogenesis in the post-ischemic brain (2005) (0)
The uptake of trimethylamine N-oxide (TMAO) and its influence on endothelial cell identity and inflammation (2021) (0)
Cardiovascular complications in CKD 5D (1) (2011) (0)
Effects of a diet supplementation with plant sterols on circulating monocytes in humans: A prospective, double-blind, randomized, placebo-controlled, cross-over study (2014) (0)
Discontinuation of Statin Treatment in Stroke Patients Comments, Opinions, and Reviews (2006) (0)
Kardiovaskulärer Risikofaktor Adipositas (2008) (0)
A case of phenotypic homozygous familial hypercholesterolemia associated with homozygosity of the LDLR variant C.798T>A P.(ASP266GLU) (2020) (0)
[Physical activity and myocardial remodeling]. (2012) (0)
Early detection of atrial fibrillation in patients with heart failure reduces the risk of subsequent hospitalization: a subanalysis of the randomized TIM-HF2 trial (2022) (0)
Long-term outcome after transcatheter mitral annuloplasty for secondary mitral regurgitation (2021) (0)
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study (2021) (0)
P291 SIMULTANEOUS DETERMINATION OF TRIGLYCERIDE AND GLUCOSE TOLERANCE BY A NOVEL SEQUENTIAL TEST PROTOCOL IN 511 PATIENTS WITH CORONARY ARTERY DISEASE (2010) (0)
Factors that Influence Bempedoic Acid-Mediated Reductions in High-sensitivity C reactive Protein: Analysis of Pooled Patient-level Data from Phase 3 Clinical Trials† (2020) (0)
Postprandial TG and Risk in Patients with CVD (2011) (0)
Assessment of Patients' Views on Drug Benefits and Risks: An Interview Study with Cardiovascular Patients (2022) (0)
Dissection of genetic determinants of fibrogenesis in liver and heart (2014) (0)
Abstract 11898: Lysyl-Oxidase Mediated Regulation of Mir-21 and Spry1 Contributes to Strcutural Remodeling During Atrial Fibrillation (2011) (0)
Neurogenic Heart Syndrome : When a Stroke Hits the Heart (0)
Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice (2019) (0)
P6434Low serum lathosterol levels predict fatal cardiovascular disease and all cause mortality: a prospective cohort study in patients admitted for coronary angiography (2018) (0)
[Cardiologic Check-ups]. (2019) (0)
Contemporary Treatment Gaps in the Implementation of Ldl Cholesterol Control Among High- And Very High-Risk Patients in Europe between 2020–2021 – The Multinational Santorini Study (2022) (0)
[Statin intolerance and statin-associated muscular pain]. (2022) (0)
Fibrotic remodeling of left ventricle in the murine remnant kidney model of chronic kidney disease is independent of arterial hypertension (2020) (0)
Abstract 676: Relation of Serum Plant Sterol Levels to Tissue Concentrations - Effects of Diet and Family History (2006) (0)
Abstract 17849: Influence of a Paclitaxel Coated Balloon in Combination With a Bare Metal Stent on Restenosis and Endothelial Function (2010) (0)
Targeting RNA elongation in endothelial-to-mesenchymal transition (2022) (0)
P1486Predictors for clinical improvement after transcatheter mitral valve repair (2018) (0)
[Elevated values of creatine kinase]. (2000) (0)
The long non-coding RNA Heat4 is dynamically regulated during cardiogenic shock (2022) (0)
Riboflavin Kinase Inhibitor 1 (RKIP1): A Potential Modifier of Fibrogenesis in Liver and Heart (2015) (0)
Decrease of RNA editing in the failing heart leads to induction of circRNAs (2022) (0)
The year in cardiology: cardiovascular prevention. The year in cardiology 2019. (2020) (0)
Long‐term clinical and haemodynamic results after transcatheter annuloplasty for secondary mitral regurgitation (2021) (0)
Comments and Opinions Chronic Heart Failure and Ischemic Stroke (2011) (0)
Efficacy and Safety of Bempedoic Acid in Elderly Patients: Pooled Analyses from Phase 3 Trials (2020) (0)
Effects of surgical and FFP2 masks on cardiopulmonary exercise capacity in patients with heart failure (2022) (0)
Characteristics of Patients in the 10th and 90th Percentile of LDL-C Reductions with Alirocumab: ODYSSEY Pooled Analyses (2018) (0)
Abstract 1478: Myocardial "Anti-aging" Effects of Physical Exercise in Voluntary Running Mice (2008) (0)
P1510Prospective study of fasting and postprandial chylomicron triglyceride content and cardiovascular events in patients with stable coronary artery disease (2017) (0)
Erratum to: LDL-Cholesterol: Standards of Treatment 2016: A German Perspective (2016) (0)
Genetic Variants Related to Combined Exposure to both Lower Low- Density Lipoproteins and Lower Systolic Blood Pressure with Lifetime Risk of Cardiovascular Disease. JAMA Network Open, E1-E11 (2019) (0)
Abstract 2046: The PPAR-{gamma} Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients with Coronary Artery Disease and Normal Glucose Tolerance (2007) (0)
High individual variability in LDL-reductions after inclisiran administration in a “real-world setting” (2022) (0)
Association of stroke lesion shape with newly detected atrial fibrillation – Results from the MonDAFIS study (2022) (0)
Impact of excessive supraventricular ectopic activity detected in the acute phase of stroke or TIA on AF detection and death within 24 months – results of the prospective MonDAFIS study (2021) (0)
[Update cardiology 2006/2007]. (2007) (0)
Primum non nocere: the dangers of deferring heart failure therapy (2017) (0)
Abstract 16791: Elevated Post-Prandial Triglyceride Concentrations Are Associated with an Unfavorable Cardiometabolic Risk Factor Profile in Patients with Coronary Artery Disease (2011) (0)
Abstract 12555: The Dual PPAR-α/γ Agonist Aleglitazar Enhances Arteriogenesis, Angiogenesis and Endothelial Function (2014) (0)
[Cardiovascular risk reduced under moderate LDL-C target values]. (2016) (0)
Abstract 1253: Rac1 GTPase Mediates Atrial Fibrillation (2006) (0)
["Anti-aging" from a cardiologist's view]. (2004) (0)
P5442The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling (2019) (0)
Diesel Exhaust Particles Impair Endothelial Progenitor Cells, Compromise Endothelial Integrity, Reduce Neoangiogenesis, and Increase Atherogenesis in Mice (2013) (0)
BEDSIDE Prospective study of fasting and postprandial chylomicron triglyceride content and cardiovascular events in patients with stable coronary artery disease (0)
Long-term exposure to high cholesterol accelerates cellular ageing. (2018) (0)
The possibility of postponing the ageing process through lifelong participation in football training (2018) (0)
Explosive drug information in the time of COVID-19 (2021) (0)
A novel direct inducible nongenetic murine model of diabetes-aggravated atherosclerosis (2022) (0)
Abstract 5527: Validation of a Novel Combined Oral Triglyceride Tolerance Test/Glucose Tolerance Test (2008) (0)
The dose-response of direct oral anticoagulants is non-linear at plasma levels below 100 ng/ml. (2022) (0)
[Conservative therapy of patients with stable coronary heart disease]. (2012) (0)
Abstract 12684: Development and Implementation of Blood Pressure Screening and Referral Guidelines for Community Pharmacists (2020) (0)
Lipoprotein(a): Behandlung eines unterschätzten kardiovaskulären Risikomarkers Lipoprotein(a): Treatment of a Novel Risk Factor for Cardiovascular Disease (2020) (0)
Cost-effectiveness of PCSK9 inhibitor therapy for patients with stable CAD in Germany. (2017) (0)
Case Report – Rapid Regression Of Xanthomas Under Lipoprotein Apheresis In A Boy With Homozygous Familial Hypercholesterolemia (2019) (0)
Long Noncoding RNAs in Cardiovascular Diseases (2020) (0)
Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk (2022) (0)
Abstract 13956: Physical Exercise Prior to Femoral Artery Ligation Stimulates Collateral Artery Growth in a Nitric Oxide-Dependent Manner (2011) (0)
Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen (2021) (0)
The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes (2021) (0)
In Reply. (2016) (0)
Hypercoagulability Impairs Plaque Stability in Diabetes-Induced Atherosclerosis (2022) (0)
PCV81 CURRENT TRENDS IN LIPID LOWERING THERAPY USE IN GERMANY (2019) (0)
Evaluation of coronary artery side branches (SB) with Quantitative Flow Ratio (QFR) by comparing the use of recommended angiographic projections with routine angiographic projections as Reference (2022) (0)
402 Rac1 GTPase plays a critical role in the pathogenesis of atrial fibrillation (2007) (0)
Call for an ezetimibe effectiveness test. (2018) (0)
Combined Exposure to both Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure with Lifetime Risk of Cardiovascular Disease. JAMA (2019) (0)
Inhibition of TRIF-Dependent Inflammation Decelerates Afterload-Induced Myocardial Remodeling (2022) (0)
[Functional foods. How healthy is cholesterol controlling margerine? (interview by Dr. Thomas Meissner)]. (2008) (0)
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. (2023) (0)
A Common Variant In The Nlrp3 Inflammasome Locus Associates With Mortality (2019) (0)
Left ventricular longitudinal strain in professional athletes, a useful tool to detect an athletes hearts? (2020) (0)
P5364Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials (2019) (0)
Lipid-Management 2020 – medikamentöse Therapie und Lipidapherese im Kontext (2020) (0)
Vascular effects of sterols, oxysterols, phytosterols, and oxyphytosterols in apoE-/-mice (2014) (0)
Bempedoic Acid Efficacy and Safety in High CVD Risk Patients Treated With or Without Ezetimibe: Pooled Analysis of 4 Phase 3 Clinical Trials† (2020) (0)
Abstract 5129: Importance of Heart Rate for the Effects of Chronic Mental Stress on Endothelial Function and Ischemic Stroke (2009) (0)
Abstract 18300: Myocardial Ischemia Induces Telomerase Activity in the Mouse Heart (2012) (0)
Comparison of quantitative flow ratio (QFR) and instantaneous wave-free ratio (iFR) or resting full-cycle ratio (RFR) during daily routine in the catheterization laboratory (2022) (0)
P141Raf kinase inhibitor protein mediates myocardial fibrosis in pressure overload through the regulation of the nuclear expression of nuclear factor erythroid 2-related factor 2 (2018) (0)
[Lipoprotein apheresis : State of the art and case report of the longest HELP treatment worldwide]. (2022) (0)
[Evidence-based and guideline-based treatment of heart failure]. (2016) (0)
Abstract 13791: Effects of Omega-3 Fatty Acids on Post-Prandial Triglyceride Tolerance and Monocyte Activation (2011) (0)
P399 LONG-TERM ENDURANCE EXERCISE ATTENUATES THE AGING PROCESS IN CIRCULATING LEUKOCYTES (2010) (0)
P3632Apolipoprotein C-III concentrations in chylomicron-free serum predict cardiovascular outcomes in patients with coronary artery disease (2018) (0)
[Triglycerides - assessment as risk factor and therapeutic goals]. (2022) (0)
W12 PIOGLITAZONE TREATMENT REDUCES VASCULAR SENESCENCE MARKERS AND CONFERS ANTI-APOPTOTIC EFFECTS IN THE AORTIC ENDOTHELIUM IN MICE (2010) (0)
Retrieval of an embolised occluder with an alligator forceps during staged paravalvular leakage closure (2019) (0)
Long-term effects of chronic statin treatment in the post-ischemic brain (2005) (0)
Reduced RNA editing in the failing human heart mediates alternative circular RNA splicing (2021) (0)
[Blood pressure increases with waist circumference]. (2002) (0)
Abstract 1346: Rac1 GTPase Activtiy is Associated with Atrial Fibrosis and Fibrillation (2007) (0)
Increased oxidative stress and impaired mitochondrial biogenesis and dynamics are improved by rice bran enzymatic extract diet supplementation (2016) (0)
MO031APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE BY ACTIVATING THE NALP3 INFLAMMASOME VIA A NOVEL MOLECULAR PATHWAY (2017) (0)
FO084APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION AND ORGAN DAMAGE IN CKD BY ALTERNATIVE INFLAMMASOME ACTIVATION VIA A NOVEL PATHWAY (2019) (0)
[New standard: combination therapy for the treatment of dyslipidemia]. (2022) (0)
SP280HIGH-DENSITY LIPOPROTEIN - SYMMETRIC DIMETHYLARGININE - A CKD-SPECIFIC ASSOCIATION PROMOTING PREMATURE CARDIOVASCULAR DISEASE (2016) (0)
Combined Oral Triglyceride and Glucose Tolerance Test After Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin “Cream&Sugar” Study (2022) (0)
Nitric Oxide from Neuronal No-Synthase Increases after Beta-Adrenergic Stimulation but does not Control Mitochondrial Respiration in Cardiac Myocytes (2014) (0)
P1736 Oestrogen downregulates Rac-1 GTPase mediated free radical production (2003) (0)
678 DIETARY INTAKE OF PLANT STEROL ESTER ENRICHED MARGARINE INCREASES THE SERUM CONCENTRATION OF 7P-HYDROXYSITOSTEROL IN HUMANS (2011) (0)
RESTING HEART RATE IS AN INDEPENDENT PREDICTOR OF ALL-CAUSE MORTALITY AND MYOCARDIAL INFARCTION IN THE MIDDLE-AGED GENERAL POPULATION (2015) (0)
P6288Rac1 GTPase regulates 11beta Hydroxysteroid Dehydrogenase Type 2, which is associated with structural cardiac remodeling (2017) (0)
P127 MARKERS OF CHOLESTEROL METABOLISM ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS (2010) (0)
Speckle tracking echocardiography in a patient with viral myocarditis and acute myocardial infarction Journal of Cardiology Cases (2020) (0)
Abstract 513: Metabolic Switch and Hypertrophy of Cardiomyocytes Following Angiotensin-treatment are Prevented by Activation of AMP-activated Protein Kinase (2007) (0)
Abstract 10579: Vascular Impairment by Trimethylamine N-Oxide (TMAO) Uptake and the First Description of a TMAO Transporter in Endothelial Cells (2021) (0)
Abstract 14979: Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) is a Novel Risk Predictor in Statin-Treated Coronary Artery Disease Patients (2014) (0)
In Reply. (2020) (0)
Effects of Sacubitril/Valsartan on left ventricular pressure-volume relationship in heart failure (2022) (0)
Case report: panic attacks as symptom of aortic regurgitation and aneurysm (2018) (0)
P614 CONCURRENT DISSECTION OF GENETIC DETERMINANTS OF FIBROGENESIS IN LIVER AND HEART (2014) (0)
187 Angiotensin‐induced hypertrophy of H9C2‐cells is prevented by activation of AMP‐activated protein kinase (AMPK) (2007) (0)
Anti‐PCSK 9 antibodies increase the ratios of the brain‐specific oxysterol 24S‐hydroxycholesterol to cholesterol and to 27‐hydroxycholesterol in the serum (2021) (0)
655 PLANT STEROL AND STANOL ESTERS INDUCE DIFFERENTIAL EFFECTS ON OXIDATIVE STRESS, INFLAMMATION, LEUCOCYTES, VASCULAR FUNCTION AND TISSUE CONCENTRATIONS IN MICE (2011) (0)
Phytosterol and oxyphytosterol levels in plasma and aortic valve cusps in patients with severe aortic stenosis (2014) (0)
TCT-13 Renal resistive indices, urinary albumin excretion and renal function in patients with resistant hypertension after catheter-based renal sympathetic denervation (2012) (0)
The long non-coding RNA Heat4 is elevated in heart failure patients and mediates anti-inflammatory functions thereby promoting vascular regeneration (2022) (0)
BENCH Dietary spermidine ameliorates hypertension and prevents diastolic dysfunction in Dahl salt-sensitive rats (0)
Detection of direct oral anticoagulants with the dilute Russels viper venom time – observations in a real life setting (2021) (0)
Systemic inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis during cardiac afterload (2013) (0)
Wednesday, 29 August 2012 (2012) (0)
Left atrial cardiomyopathy and 10-year risk of Atrial Fibrillation (2022) (0)
vascular cells could potentially lead to novel therapeutic strategies for the treatment of atherosclerosis and hypertension (2002) (0)
Abstract 3280: Differential Effects of Cholesterol Absorption Inhibition by Plant Sterol and Plant Stanol Esters on Expression of Monocytes, Lymphocytes, Endothelial Function, Atherogenesis and CNS Sterol Concentrations (2008) (0)
Effects of Inhibition or Deletion of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) on Intracerebral Hemorrhage Volumes in Mice. (2020) (0)
Renal artery denervation affects the circulating microRNA profile in patients with resistant arterial hypertension (2013) (0)
Abstract 16862: Afterload-Induced Myocardial Fibrosis is Promoted by TRIF-Dependent Inflammation (2012) (0)
Regulation positive de l'oxyde nitrique synthase des cellules endotheliales de type iii par des inhibiteurs de la hmg-coa reductase (2000) (0)
Erratum zu: Neue AHA- und ACC-Leitlinie zur Risikoreduktion von Herz-Kreislauf-Erkrankungen durch Cholesterinsenkung. Stellungnahme der D•A•CH-Gesellschaft Prävention von Herz-Kreislauf-Erkrankungen e. V., der Österreichischen Atherosklerose Gesellschaft und der Arbeitsgruppe Lipide und Atherosklero (2014) (0)
[Diagnostic methods and differential diagnosis of heart failure]. (2016) (0)
Post-Covid-Syndrom: Wie diagnostizieren, wie behandeln? (2022) (0)
[Treatment and LDL cholesterol adjustment in patients with high and very high cardiovascular risk in Germany compared with Europe - data from the SANTORINI registry]. (2023) (0)
P1585Fibrotic myocardial remodeling is regulated by rkip and nrf2 depending on redox status (2017) (0)
Herz oder Hirn? (2013) (0)
Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10. (2023) (0)
Gehen hohe HDL-Werte immer mit einem reduzierten Infarktrisiko einher? – Senkung des LDL-Cholesterins bleibt im Vordergrund der Lipidtherapie (2012) (0)
Weitere kardiovaskuläre Risikofaktoren (2000) (0)
Leptin mediates protective effects on the vasculature (2022) (0)
In‐Hospital ECG Findings, Changes in Medical Management, and Cardiovascular Outcomes in Patients With Acute Stroke or Transient Ischemic Attack (2023) (0)
Prävention des Schlaganfalls durch Behandlung des Vorhofflimmerns: Neue Hoffnung durch Dronedaron und Dabigatran? (2010) (0)
Behandlung und LDL-Cholesterin-Einstellung von Patienten mit hohem und sehr hohem kardiovaskulärem Risiko in Deutschland und im europäischen Vergleich – Daten des SANTORINI-Registers (2023) (0)
HDL und Arteriosklerose – Korrelation mit dem Auftreten kardiovaskulärer Ereignisse (2010) (0)
Abstract 19044: Metabolic Syndrome and Diabetes Mellitus Determine the Absolute and Relative Triglyceride Metabolism Following a Sequential Triglyceride and Glucose Tolerance Test in 514 Patients With Coronary Artery Disease (2010) (0)
PCSK9-Hemmung – ein Update (2022) (0)
Stabile koronare Herzerkrankung - Quiz zur Zertifizierung (2006) (0)
Regelmäßige körperliche Aktivtität induziert Neo-Vaskularisation, steigert Kapillardichte und zerebralen Blutfluss und schützt vor zerebraler Ischämie (2004) (0)
Lipidsenkung jenseits des LDL-Cholesterins (2021) (0)
Therapieoptionen zur LDL-C-Senkung zusätzlich zu Statinen (2022) (0)
Familiäre Hypercholesterinämie in Deutschland Familial Hypercholesterolemia in Germany (2020) (0)
Gesundheitsökonomische Aspekte der Verschreibung von PCSK9-Hemmern (2018) (0)
P3557Heart failure patients show increase of white matter lesions in MRI-imaging: LIFE-Adult-Study (2019) (0)
Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 3) (2023) (0)
Abstract 14248: Efficacy and Safety of Bempedoic Acid in Patients Who Cannot Tolerate Statins: Pooled Analysis of 4 Phase 3 Clinical Trials (2020) (0)
Aktuelle Kardiologie 2006/2007 (2007) (0)
Erratum zu: Update Therapie der Herzinsuffizienz 2019 (2020) (0)
Körperliche Aktivität und myokardiales Remodelling (2012) (0)
Induction of Endothelial-Leukocyte Interaction by Interferon-&ggr; Requires Coactivation of Nuclear Factor-&kgr;B (2001) (0)
[Therapeutic options to reduce LDL-cholesterol beyond statins]. (2022) (0)
Statine und neue Therapieoptionen zur Behandlung der LDL-Hypercholesterinämie (2020) (0)
Lipoprotein(a) (2022) (0)
Fettstoffwechselstörungen in der Schwangerschaft (2008) (0)
Prophylaxe bei stabiler ischämischer Herzkrankheit: Kardiovaskuläres Risiko unter moderaten LDL-C-Werten verringert (2016) (0)
Abstract 12268: Efficacy of Bempedoic Acid: A Pooled Analysis of 4 Pivotal Phase 3 Clinical Trials (2019) (0)
Brauchen alle Patienten mit KHK bzw. Diabetes ein Statin? (2009) (0)
Herz, Gefäße, Lunge (2004) (0)
Hyperlipoproteinämie – wie behandeln? (2012) (0)
Brauchen wir neue Zielwerte - Wie tief muss das LDL-Cholesterin gesenkt werden? (2006) (0)
2019 Leitlinie Dyslipidämie kompakt (2020) (0)
Schnittstelle Herz und Hirn (2011) (0)
Liebe Leserinnen, liebe Leser, (2020) (0)
Inhibitionofendothelialnitricoxidesynthaseinduces and enhances myocardial fibrosis (2013) (0)
Correction to: Response to Letter to the editors of Hopkins et al.: Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity: the numbers do not add up (2021) (0)
Junge Frau mit isolierter Lipoprotein(a)-Erhöhung (2013) (0)
Erratum (2006) (0)
[The heart failure patient with acute dyspnea and weight gain]. (2016) (0)
Neue Therapiekonzepte für die Herzinsuffizienz (2021) (0)
Spezifische Behandlung der Lipoprotein(a)-Hyperlipoproteinämie (2020) (0)
Vorsorgeuntersuchungen und Check-ups in der Kardiologie (2019) (0)
[Lp(a) and its role in cardiovascular diseases]. (2022) (0)
Preventing stroke by treating atrial fibrillation (2010) (0)
Neuer Standard: Kombinationstherapie zur Behandlung von Fettstoffwechselstörungen (2022) (0)
Behandlung von Fettstoffwechselstörungen (2016) (0)
1998Long-term hemodynamic improvement after percutaneous mitral valve repair in the noninvasive pressure-volume analysis (2017) (0)
Kardiologie: Lipidsenkung durch Rosuvastatin: Wie unterscheiden sich Statine? (2015) (0)
Abstract 13721: Heart Rate Reduction by If-Channel Blockade With Ivabradine Stimulates Collateral Artery Growth in Hypercholesterolemic Atherosclerosis (2011) (0)
Erratum zu: Primärprävention der koronaren Herzkrankheit (2020) (0)
Cardiac metabolism during atrial fibrillation is characterized by increased lipid accumulation and glycogen synthesis (2013) (0)
Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis. (2023) (0)
MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE (2017) (0)
Rhythmusstörungen bei chronischen Autoimmunerkrankungen (2019) (0)
Familiäre Hypercholesterinämie in Deutschland (2020) (0)
Hemmung der Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (2013) (0)
Regional differences of G protein alpha-subunit mRNA expression in the heart and other tissues (1994) (0)
Xanthome verschwinden, Atherosklerose bleibt (2018) (0)
Bedeutung des Mineralocorticoid-Rezeptors für die Entstehung atrialer Fibrose bei Vorhofflimmern (2013) (0)
Triglyzeride – Aktuelle Bewertung als Risikomarker und Therapieziele (2022) (0)
Moderne Lipidsenker – ein Mittel gegen das Problem der Unterversorgung? (2022) (0)
Efficacy of Alirocumab Treatment on Lipoproteins At Week 12: Pooled Analyses of 10 ODYSSEY Phase 3 Trials (2017) (0)
Detailed analysis of cholesterol metabolism predicts cardiovascular events in patients admitted for coronary angiography. (2017) (0)
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. (2023) (0)
Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form (2023) (0)
First case report of the use of two stents following coronary artery obstruction during indirect mitral annuloplasty. (2023) (0)
4135Left atrial appendage regional wall movement analysis using tissue velocity imaging (2018) (0)
Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study (2020) (0)
P4997Raf kinase inhibitor protein of the bone marrow contributes to cardiac fibrogenesis in pressure-overloaded myocardium (2019) (0)
Cardiovascular risk algorithms in primary care: Results from the DETECT study (2019) (0)
P6437Heart rate reduction with ivabradine restores endothelial function and reduces vascular stiffness in patients with chronic stable coronary artery disease (2018) (0)
Central hemodynamic effects in patients with chronic coronary syndrome after long-term ivabradine therapy (2020) (0)
Evaluating patients’ comprehensibility of a standardized medication plan (2016) (0)
Extracellular inflammasomes as novel endogenous danger signals that exert pro-inflammatory signaling on vascular cells (2020) (0)
P2701Comparison of myocardial ischemia assessed by contrast-flow quantitative flow ratio (cQFR) and by stress MRI in patients with stable coronary artery disease (2019) (0)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation (2019) (0)
P2496Acute stress and ischemic stroke lead to heart remodeling and autonomic imbalance in a mouse model (2018) (0)
P1367 Prevalence of left ventricular hypertrophy, diastolic dysfunction and pulmonary hypertension in patients with severe aortic valve stenosis (2020) (0)
Left ventricular mechanical dispersion in flow-gradient patterns of severe aortic stenosis (2020) (0)
P660Effects of soccer training on telomere length and telomerase activity in young and aged soccer players (2018) (0)
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the international lipid expert panel (ILEP). (2023) (0)
P1544No associations of plasma oxyphytosterol levels and cardiovascular events in patients admitted for coronary angiography (2018) (0)
[Stable coronary artery disease -- diagnosis and therapy]. (2006) (0)
The Neural Representation of the Heart is Strongly Attenuated in Patients with Atrial Fibrillation (2022) (0)
P1542High intensity physical activity during marathon running increases endothelial microparticles (2017) (0)
370 SYSTEMIC AND ORGAN-SPECIFIC GENETIC DETERMINANTS OF FIBROGENESIS IN LIVER AND HEART (2012) (0)
[Heart or brain? Problem patients at the interface between cardiology and neurology]. (2013) (0)
[Update on PCSK9 inhibition]. (2022) (0)
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey (2020) (0)
Metabolic Syndrome and Heart Failure (2006) (0)
Abstract 2428: Role of Rac1, Connective Tissue Growth Factor and Lysyl Oxidase for Atrial Fibrosis in Atrial Fibrillation (2009) (0)
Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses. (2023) (0)
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study. (2022) (0)
Levels and dynamics of estimated glomerular filtration rate and recurrent vascular events and death in patients with minor stroke or transient ischemic attack (2022) (0)
Contents Vol. 25, 2008 (2008) (0)
CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE (2017) (0)
[Does atrial fibrillation cause cryptogenic stroke? - Embolic Stroke of Undetermined Source (ESUS) first requires interdisciplinary diagnostic investigation]. (2014) (0)
Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats (2016) (0)
Abstract 477: Selective Heart Rate Reduction Via Inhibition Of The IF-current Prevents Atherosclerosis And Improves Endothelial And Erectile Function In Apoe / Mice (2007) (0)
HOW EFFECTIVE IS RENAL DENERVATION IN LESS SEVERE TREATMENT RESISTANT HYPERTENSION (2013) (0)
WITHDRAWN: Corrigendum to "Red wine prevents the acute negative vascular effects of smoking". (2016) (0)
[Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels]. (2012) (0)
Effects of heart rate and selective heart rate reduction on vascular wall morphology and elastic properties in dyslipidemic mice (2013) (0)
Abstract 10966: Characterization of the Novel Cardiac Splicing Factor Slm2 in Heart Failure, Which Regulates Splicing of Titin (2021) (0)
Abstract 4325: Long-term Effects of Early versus Late PCI After Thrombolysis in Acute Myocardial Infarction (2009) (0)
Prognostic value of secondary cardiac alterations in patients with moderate aortic valve stenosis (2021) (0)
Andrey Kazakov and Ulrich Laufs Diseases Healthy and Unhealthy Cardiac Progenitor Cells Modify the Pathogenesis of Myocardial (2016) (0)
Abstract 4887: The Thiazolidinedione Pioglitazone up-regulates Vascular Telomere Regulating Proteins and Prevents Cellular Senescence in Mice (2009) (0)
Abstract 17056: Telomerase Reverse Transcriptase (TERT) and Endothelial NO Synthase (eNOS) Mediate Vascular Anti-Senescent and Endothelial-Protective Effects of Physical Exercise (2010) (0)
Left ventricular hypertrophy, diastolic dysfunction and right ventricular load predict outcome in moderate aortic stenosis (2023) (0)
Correction to: Response to the letter to the editor by Kampert et al. entitled “Impact of wearing a facial covering on aerobic exercise capacity in the COVID‑19 Era: is it more than a feeling?” (2021) (0)
Native T1 mapping for differential diagnosis of left ventricular hypertrophy (2021) (0)
The year in cardiology: cardiovascular prevention /The year in cardiology 2019 (2020) (0)
Matthias Endres and Ulrich Laufs Discontinuation of Statin Treatment in Stroke Patients (2006) (0)
The German CaRe High Registry for Familial Hypercholesterolemia –Sex Differences, Treatment Strategies and Target Value Attainment (2022) (0)
Prevalence of cutaneous manifestations in clinically diagnosed familial hypercholesterolemia (2021) (0)
[Statins as new therapeutic possibility in osteoporosis?]. (2001) (0)
IS110 Keynote lecture : Novel Cholesterol-Independent Effects of HMG-CoA Reductase Inhibitors (1999) (0)
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study (2020) (0)
Abstract 17393: Markers of Cholesterol Metabolism Predict Cardiovascular Events (2017) (0)
Why doesn’t high cholesterol hurt? (2019) (0)
The impact of cholesterol lowering drugs on metabolism and epigenetics (2022) (0)
Comparison of fibrogenesis in liver and heart: systemic and organ specific genetic determinants of experimental fibrosis (2011) (0)
Signs of left atrial disease and 10-year risk of atrial fibrillation (2022) (0)
Statin-Therapie: mehr UE in unverblindeten vs. verblindeten Studiensituationen (2017) (0)
[Lipid lowering by rosuvastatin: how do statins differ?]. (2015) (0)
Lipoprotein(a) does not have a clinically significant arterial or venous prothrombotic effect (2022) (0)
Studien Bempedoic Acid – Mechanism of Action and Clinical Trials (2020) (0)
SP340CHANGES IN FGF-23 PLASMA-LEVELS BEFORE AND AFTER SUCCESSFUL ELECTRIC CARDIOVERSION IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION (2015) (0)
The impact of upright posture on left ventricular deformation in athletes. (2023) (0)
The importance of heart rate control in the management of heart failure (2010) (0)
Characteristics of patients with a lipoprotein(a) assessment – a health insurance claims database analysis (2021) (0)
Reply to letter: pulsatile venoarterial perfusion using a novel synchronized cardiac assist device augments coronary artery blood flow during ventricular fibrillation. (2015) (0)
Rac1 GTPase mediates atrial fibrillation via activation of NADPH oxidase (2007) (0)
Statinintoleranz und statinassoziierte Muskelschmerzen (2022) (0)
Food supplementation with rice bran enzymatic extract prevents vascular senescence and atherogenesis in APoE-/- mice (2015) (0)
[Lipid metabolism disorders in pregnancy]. (2008) (0)
Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients (2022) (0)
TCT-211 Ambulatory blood pressure and dipping-pattern after catheter-based renal sympathetic denervation in patients with resistant hypertension (2012) (0)
Coronary Balloon Angioplasty is due to two physicians born in Saxony, Germany. (2020) (0)
[Modern lipid-lowering drugs-A means to counter the problem of undertreatment?] (2022) (0)
415-P: Leptin Treatment Has Vasculoprotective Effects in Lipodystrophic Mice (2022) (0)
Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins (2017) (0)
Abstract 10192: Circular RNA Formation in the Failing Heart is Enhanced by the Reduction of Adenosine-to-Inosine RNA Editing (2021) (0)
Abstract 10499: The Heart Failure-Induced Long Non-Coding RNA Heat4 Reduces the Inflammatory Response of Non-Classical Monocytes and Mediates Regeneration After Vascular Injury (2021) (0)
[Interface between heart and brain: challenges and opportunities]. (2011) (0)
NO from neuronal NO synthase increases after beta-adrenergic stimulation but does not control mitochondrial respiration (2012) (0)
Low-fat diet and exercise are more important. In reply. (2015) (0)
FO005SERUM AMYLOID A (SAA) AND HIGH DENSITY LIPOPROTEINS (HDL) INTERACTION AND CARDIOVASCULAR RISK IN RENAL PATIENTS (2015) (0)
Abstract WP214: Levels And Dynamics Of Estimated Glomerular Filtration Rate And Clinical Outcomes In Patients With Stroke Or Tia - Results Of The Mondafis Trial (2022) (0)
Association of the postprandial chylomicron triglyceride/ApoB index and cardiovascular events (2016) (0)
Abstract 18134: Importance of Fasting And Postprandial Triglycerides for Risk Prediction in Stable Coronary Disease - 24 Months Follow-up (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ulrich Laufs?

Ulrich Laufs is affiliated with the following schools:

Ulrich Laufs's Academic­Influence.com Rankings

Why Is Ulrich Laufs Influential?

Ulrich Laufs's Published Works

Published Works

What Schools Are Affiliated With Ulrich Laufs?

Ulrich Laufs's AcademicInfluence.com Rankings